These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 19132480
1. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria. Tokuhara T, Tanigawa N, Matsuki M, Nomura E, Mabuchi H, Lee SW, Tatsumi Y, Nishimura H, Yoshinaka R, Kurisu Y, Narabayashi I. Gastric Cancer; 2008; 11(4):194-200. PubMed ID: 19132480 [Abstract] [Full Text] [Related]
2. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10. Tatsumi Y, Tanigawa N, Nishimura H, Nomura E, Mabuchi H, Matsuki M, Narabayashi I. Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368 [Abstract] [Full Text] [Related]
3. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Harada T, Tanigawa N, Matsuki M, Nohara T, Narabayashi I. Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053 [Abstract] [Full Text] [Related]
4. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. Memarsadeghi M, Riedl CC, Kaneider A, Galid A, Rudas M, Matzek W, Helbich TH. Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065 [Abstract] [Full Text] [Related]
5. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. Koh DM, George C, Temple L, Collins DJ, Toomey P, Raja A, Bett N, Farhat S, Husband JE, Brown G. AJR Am J Roentgenol; 2010 Jun; 194(6):W505-13. PubMed ID: 20489069 [Abstract] [Full Text] [Related]
6. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I. J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430 [Abstract] [Full Text] [Related]
7. High-Accuracy Nodal Staging of Head and Neck Cancer With USPIO-Enhanced MRI: A New Reading Algorithm Based on Node-to-Node Matched Histopathology. Driessen DAJJ, Zámecnik P, Dijkema T, Pegge SAH, van Engen-van Grunsven ACH, Takes RP, Kaanders JHAM, Scheenen TWJ. Invest Radiol; 2022 Dec 01; 57(12):810-818. PubMed ID: 35776432 [Abstract] [Full Text] [Related]
8. Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study. Pultrum BB, van der Jagt EJ, van Westreenen HL, van Dullemen HM, Kappert P, Groen H, Sietsma J, Oudkerk M, Plukker JT, van Dam GM. Cancer Imaging; 2009 Apr 06; 9(1):19-28. PubMed ID: 19414293 [Abstract] [Full Text] [Related]
11. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results. Kimura K, Tanigawa N, Matsuki M, Nohara T, Iwamoto M, Sumiyoshi K, Tanaka S, Takahashi Y, Narumi Y. Breast Cancer; 2010 Oct 06; 17(4):241-6. PubMed ID: 19575282 [Abstract] [Full Text] [Related]
12. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model. Choi SH, Moon WK, Hong JH, Son KR, Cho N, Kwon BJ, Lee JJ, Chung JK, Min HS, Park SH. Radiology; 2007 Jan 06; 242(1):137-43. PubMed ID: 17090719 [Abstract] [Full Text] [Related]
13. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. Koh DM, Brown G, Temple L, Raja A, Toomey P, Bett N, Norman AR, Husband JE. Radiology; 2004 Apr 06; 231(1):91-9. PubMed ID: 14976266 [Abstract] [Full Text] [Related]
15. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Deserno WM, Harisinghani MG, Taupitz M, Jager GJ, Witjes JA, Mulders PF, Hulsbergen van de Kaa CA, Kaufmann D, Barentsz JO. Radiology; 2004 Nov 06; 233(2):449-56. PubMed ID: 15375228 [Abstract] [Full Text] [Related]
16. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, Vermathen P, Fleischmann A, Thoeny HC. Eur Urol; 2013 Dec 06; 64(6):953-60. PubMed ID: 23916692 [Abstract] [Full Text] [Related]
17. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM, Group. Radiology; 2003 Sep 06; 228(3):777-88. PubMed ID: 12954896 [Abstract] [Full Text] [Related]
18. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR. AJR Am J Roentgenol; 1999 May 06; 172(5):1347-51. PubMed ID: 10227514 [Abstract] [Full Text] [Related]